Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) deadline 2026
The current listed application deadline is May 4, 2026. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.
Application Countdown
Use this page as the fast check for timing, then jump into the full grant record for filters, drafting, and comparison.
Quick facts
- Opportunity number
- PAR-25-106
- Last updated
- November 21, 2024
- Expected awards
- Not listed
Deadline summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed...
Key dates
Before you apply
Eligibility snapshot
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
